Arcutis Biotherapeutics Inc (ARQT)
9.43
+0.17
(+1.84%)
USD |
NASDAQ |
Nov 18, 16:00
9.53
+0.10
(+1.06%)
Pre-Market: 08:40
Arcutis Biotherapeutics Total Liabilities (Quarterly): 280.71M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 280.71M |
| June 30, 2024 | 258.33M |
| March 31, 2024 | 253.60M |
| December 31, 2023 | 252.70M |
| September 30, 2023 | 246.24M |
| June 30, 2023 | 240.18M |
| March 31, 2023 | 239.73M |
| December 31, 2022 | 239.69M |
| September 30, 2022 | 238.14M |
| June 30, 2022 | 105.08M |
| March 31, 2022 | 110.34M |
| Date | Value |
|---|---|
| December 31, 2021 | 110.48M |
| September 30, 2021 | 24.01M |
| June 30, 2021 | 18.40M |
| March 31, 2021 | 20.42M |
| December 31, 2020 | 27.65M |
| September 30, 2020 | 24.94M |
| June 30, 2020 | 23.05M |
| March 31, 2020 | 12.51M |
| December 31, 2019 | 172.04M |
| September 30, 2019 | 81.25M |
| December 31, 2018 | 75.08M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
12.51M
Minimum
Mar 2020
280.71M
Maximum
Sep 2024
144.91M
Average
141.26M
Median
Total Liabilities (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | 435.87M |
| Biogen Inc | 11.95B |
| Vertex Pharmaceuticals Inc | 6.609B |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 437.35M |
| Shareholders Equity (Quarterly) | 156.64M |
| Debt to Equity Ratio | 1.306 |
| Current Ratio | 2.457 |
| Net Debt Paydown Yield | -0.09% |